Detalles de la búsqueda
1.
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with ("pseudo-randomized") treatment allocation by the health insurance provider.
J Neurooncol
; 148(2): 373-379, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409944
2.
Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
Strahlenther Onkol
; 192(3): 146-55, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26646311
3.
Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
Strahlenther Onkol
; 192(3): 156, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26809739
4.
Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial.
Front Neurol
; 8: 296, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28690586
5.
Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
Radiat Oncol
; 9(1): 89, 2014 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24678590
6.
Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Radiother Oncol
; 104(2): 181-6, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22853851
Resultados
1 -
6
de 6
1
Próxima >
>>